Bryan Stuart | President, Chief Executive Officer |
Chris Morabito | Chief Medical Officer |
Peter Thomson | Vice President of Finance & Accounting |
Judy Dunn | President of R&D |
Paul Bruno | Senior Director of Corporate Development |
Naomi Aoki | Senior Vice President of Corporate Communications, Investor Relations |
Dae Gon Ha | Stiefel |
Ted Tenthoff | Piper Sandler |
Kostas Biliouris | Morgan Stanley |
Joseph Schwartz | SVB Leerink |
Judah Frommer | Credit Suisse |
Good morning, and welcome to the Fulcrum Therapeutics, Third Quarter 2021 Conference Call. Currently all participants are in listen-only mode. There will be a question-and-answer session at the end of this call. I would now like to turn the call over to Naomi Aoki, Senior Vice President of Corporate Communications and Investor Relations of Fulcrum. Ma'am, please proceed.